This further indicates that up to 10% of CML patients may have CHIP-related mutations and reinvigorates earlier hypotheses of a multistep pathogenesis of CML – arising, at least in some cases, from pluripotent stem cells of a pre-existing Ph- clone that enjoys a growth advantage. Here, STUB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.